APOA2 antibody (HRP)
Quick Overview for APOA2 antibody (HRP) (ABIN7449328)
Target
See all APOA2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Goat anti-Human Apo AII [H04] Antibody HRP Conjugated
-
Immunogen
- Human Apolipoprotein AII
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB: 1:1,000 - 1:8,000
ELISA: 1:1,000 - 1:8,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 50 mM PBS, 0.1 M NaCl, and 0.01 % Thiomersal, pH 7.4
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Expiry Date
- 12 months
-
-
- APOA2 (Apolipoprotein A-II (APOA2))
-
Alternative Name
- ApoAII
-
Background
- Background: Apo AII comprises 25 % of HDL. It exists in human plasma as a dimer of 2 identical chains of 77 amino acid residues, joined by disulfide. The molecular weight is reported to be 8.7 kDa for a single chain (Brewer et al., 1972).Studies on mouse reported that apo AII may be proatherogenic (Warden et al., 1993), however, case-control study in the large European Prospective Investigation demonstrated that plasma Apo AII concentrations were strongly inversely correlated with CHD events. (Birjmohun et al., 2007)
-
Gene ID
- 336
-
NCBI Accession
- NP_001634
-
UniProt
- P02652
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Target
-